| 0 |
ARTERIOVENOUS GRAFT PLACEMENT |
1 |
0.5000 |
| 1 |
AIRWAY COMPRESSION |
1 |
0.0270 |
| 2 |
PERINEAL SWELLING |
1 |
0.0208 |
| 3 |
HEREDITARY ANGIOEDEMA |
215 |
0.0200 |
| 4 |
DISEASE PRODROMAL STAGE |
1 |
0.0196 |
| 5 |
JUGULAR VEIN OCCLUSION |
1 |
0.0154 |
| 6 |
HYPOBARISM |
1 |
0.0067 |
| 7 |
RESTLESS ARM SYNDROME |
1 |
0.0064 |
| 8 |
GALLBLADDER HYPOFUNCTION |
1 |
0.0058 |
| 9 |
INJECTION SITE PALLOR |
1 |
0.0032 |
| 10 |
POLYCYSTIC OVARIAN SYNDROME |
1 |
0.0026 |
| 11 |
RESPIRATORY TRACT INFECTION FUNGAL |
1 |
0.0019 |
| 12 |
OPHTHALMIC MIGRAINE |
1 |
0.0014 |
| 13 |
GASTROINTESTINAL OEDEMA |
2 |
0.0011 |
| 14 |
JAW OPERATION |
1 |
0.0011 |
| 15 |
SELECTIVE EATING DISORDER |
1 |
0.0011 |
| 16 |
CARPAL TUNNEL DECOMPRESSION |
1 |
0.0009 |
| 17 |
INJECTION SITE INDENTATION |
2 |
0.0009 |
| 18 |
PARANASAL SINUS DISCOMFORT |
3 |
0.0008 |
| 19 |
HEPATIC INFECTION |
1 |
0.0008 |
| 20 |
MAST CELL ACTIVATION SYNDROME |
1 |
0.0007 |
| 21 |
PANCREATIC ENZYMES INCREASED |
1 |
0.0007 |
| 22 |
INTERCEPTED MEDICATION ERROR |
3 |
0.0006 |
| 23 |
COAGULATION TIME PROLONGED |
1 |
0.0006 |
| 24 |
INJECTION SITE DISCOLOURATION |
8 |
0.0006 |
| 25 |
PHARYNGEAL SWELLING |
6 |
0.0006 |
| 26 |
EROSIVE OESOPHAGITIS |
1 |
0.0006 |
| 27 |
CARDIAC DISCOMFORT |
1 |
0.0005 |
| 28 |
SPINAL FUSION SURGERY |
2 |
0.0005 |
| 29 |
CATHETER SITE PAIN |
1 |
0.0004 |
| 30 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 31 |
HYPOMENORRHOEA |
1 |
0.0004 |
| 32 |
UPPER RESPIRATORY TRACT CONGESTION |
1 |
0.0003 |
| 33 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 34 |
INJECTION SITE VESICLES |
2 |
0.0003 |
| 35 |
EMERGENCY CARE |
1 |
0.0003 |
| 36 |
PROSTATITIS |
1 |
0.0003 |
| 37 |
INJECTION SITE RASH |
10 |
0.0003 |
| 38 |
PRODUCT DISTRIBUTION ISSUE |
3 |
0.0003 |
| 39 |
INJECTION SITE DISCOMFORT |
3 |
0.0003 |
| 40 |
PRODUCT STORAGE ISSUE |
1 |
0.0003 |
| 41 |
UPPER RESPIRATORY TRACT INFECTION |
12 |
0.0003 |
| 42 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0003 |
| 43 |
INJECTION SITE BRUISING |
20 |
0.0003 |
| 44 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 45 |
GENERALISED OEDEMA |
3 |
0.0002 |
| 46 |
MUSCLE STRAIN |
2 |
0.0002 |
| 47 |
HORDEOLUM |
1 |
0.0002 |
| 48 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 49 |
PRODUCT AVAILABILITY ISSUE |
5 |
0.0002 |
| 50 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 51 |
INJECTION SITE ERYTHEMA |
27 |
0.0002 |
| 52 |
GASTRITIS EROSIVE |
1 |
0.0002 |
| 53 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 54 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 55 |
INJECTION SITE INFLAMMATION |
1 |
0.0002 |
| 56 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
1 |
0.0002 |
| 57 |
INTESTINAL RESECTION |
1 |
0.0002 |
| 58 |
FAECALOMA |
1 |
0.0002 |
| 59 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 60 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 61 |
ABDOMINAL DISTENSION |
18 |
0.0002 |
| 62 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 63 |
SINUS HEADACHE |
1 |
0.0002 |
| 64 |
INJECTION SITE URTICARIA |
4 |
0.0002 |
| 65 |
NASAL DRYNESS |
1 |
0.0002 |
| 66 |
MENINGITIS |
1 |
0.0001 |
| 67 |
SINUS CONGESTION |
2 |
0.0001 |
| 68 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 69 |
INJECTION SITE SWELLING |
11 |
0.0001 |
| 70 |
SWELLING |
13 |
0.0001 |
| 71 |
SWELLING FACE |
9 |
0.0001 |
| 72 |
INJECTION SITE PRURITUS |
9 |
0.0001 |
| 73 |
INJECTION SITE PAIN |
41 |
0.0001 |
| 74 |
INJECTION SITE REACTION |
9 |
0.0001 |
| 75 |
CONCUSSION |
1 |
0.0001 |
| 76 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 77 |
BRAIN FOG |
2 |
0.0001 |
| 78 |
POLYURIA |
1 |
0.0001 |
| 79 |
MYOPATHY |
1 |
0.0001 |
| 80 |
HYSTERECTOMY |
1 |
0.0001 |
| 81 |
PYELONEPHRITIS |
1 |
0.0001 |
| 82 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 83 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 84 |
PERIPHERAL SWELLING |
17 |
0.0001 |
| 85 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 86 |
APPENDICITIS |
1 |
0.0001 |
| 87 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 88 |
COELIAC DISEASE |
1 |
0.0001 |
| 89 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 90 |
EAR DISCOMFORT |
1 |
0.0001 |
| 91 |
SWOLLEN TONGUE |
3 |
0.0001 |
| 92 |
DERMATITIS |
2 |
0.0001 |
| 93 |
BACK INJURY |
1 |
0.0001 |
| 94 |
LIP SWELLING |
3 |
0.0001 |
| 95 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 96 |
VASCULITIS |
1 |
0.0001 |
| 97 |
SPLENOMEGALY |
1 |
0.0001 |
| 98 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 99 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 100 |
OEDEMA |
4 |
0.0001 |
| 101 |
ROAD TRAFFIC ACCIDENT |
3 |
0.0001 |
| 102 |
APHONIA |
1 |
0.0001 |
| 103 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 104 |
INJECTION SITE HAEMATOMA |
1 |
0.0001 |
| 105 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 106 |
ABDOMINAL DISCOMFORT |
11 |
0.0001 |
| 107 |
INSURANCE ISSUE |
1 |
0.0001 |
| 108 |
ABDOMINAL PAIN |
15 |
0.0001 |
| 109 |
INFLUENZA |
7 |
0.0001 |
| 110 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
11 |
0.0001 |
| 111 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 112 |
SINUSITIS |
6 |
0.0001 |
| 113 |
SCAR |
1 |
0.0001 |
| 114 |
ILLNESS |
6 |
0.0001 |
| 115 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 116 |
DEVICE USE ERROR |
2 |
0.0001 |
| 117 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 118 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 119 |
URINARY TRACT INFECTION |
9 |
0.0001 |
| 120 |
FOOT FRACTURE |
1 |
0.0001 |
| 121 |
FEELING JITTERY |
1 |
0.0001 |
| 122 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 123 |
CONTUSION |
5 |
0.0001 |
| 124 |
ERUCTATION |
1 |
0.0001 |
| 125 |
CHOKING |
1 |
0.0001 |
| 126 |
ORAL HERPES |
1 |
0.0001 |
| 127 |
KIDNEY INFECTION |
1 |
0.0001 |
| 128 |
WHEEZING |
3 |
0.0001 |
| 129 |
SINUS DISORDER |
1 |
0.0001 |
| 130 |
SPINAL FRACTURE |
1 |
0.0000 |
| 131 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 132 |
HEADACHE |
31 |
0.0000 |
| 133 |
ILL-DEFINED DISORDER |
3 |
0.0000 |
| 134 |
FEEDING DISORDER |
1 |
0.0000 |
| 135 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 136 |
JOINT INJURY |
1 |
0.0000 |
| 137 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 138 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 139 |
ANGIOEDEMA |
2 |
0.0000 |
| 140 |
ORAL PAIN |
1 |
0.0000 |
| 141 |
URTICARIA |
7 |
0.0000 |
| 142 |
LOCALISED INFECTION |
1 |
0.0000 |
| 143 |
ATRIAL FIBRILLATION |
4 |
0.0000 |
| 144 |
DYSPEPSIA |
4 |
0.0000 |
| 145 |
EPISTAXIS |
3 |
0.0000 |
| 146 |
FLUSHING |
4 |
0.0000 |
| 147 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 148 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 149 |
FEAR |
1 |
0.0000 |
| 150 |
RASH PRURITIC |
2 |
0.0000 |
| 151 |
PALLOR |
1 |
0.0000 |
| 152 |
FEELING COLD |
1 |
0.0000 |
| 153 |
PAIN IN JAW |
1 |
0.0000 |
| 154 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 155 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 156 |
ANGINA PECTORIS |
1 |
0.0000 |
| 157 |
LETHARGY |
2 |
0.0000 |
| 158 |
DYSSTASIA |
1 |
0.0000 |
| 159 |
DYSPHONIA |
2 |
0.0000 |
| 160 |
DIZZINESS |
17 |
0.0000 |
| 161 |
NASAL CONGESTION |
2 |
0.0000 |
| 162 |
PRODUCT DOSE OMISSION ISSUE |
10 |
0.0000 |
| 163 |
FEELING HOT |
2 |
0.0000 |
| 164 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 165 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 166 |
CHOLELITHIASIS |
1 |
0.0000 |
| 167 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 168 |
TREMOR |
5 |
0.0000 |
| 169 |
SYNCOPE |
3 |
0.0000 |
| 170 |
URINARY RETENTION |
1 |
0.0000 |
| 171 |
SOMNOLENCE |
6 |
0.0000 |
| 172 |
MALAISE |
13 |
0.0000 |
| 173 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 174 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 175 |
ABDOMINAL PAIN UPPER |
6 |
0.0000 |
| 176 |
RASH MACULAR |
1 |
0.0000 |
| 177 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 178 |
INJECTION SITE MASS |
1 |
0.0000 |
| 179 |
SEIZURE |
3 |
0.0000 |
| 180 |
PALPITATIONS |
3 |
0.0000 |
| 181 |
CARDIAC FAILURE |
2 |
0.0000 |
| 182 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 183 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 184 |
NAUSEA |
19 |
0.0000 |
| 185 |
POLLAKIURIA |
1 |
0.0000 |
| 186 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 187 |
FATIGUE |
18 |
0.0000 |
| 188 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 189 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 190 |
LIVER DISORDER |
1 |
0.0000 |
| 191 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 192 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 193 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 194 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 195 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 196 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 197 |
NASOPHARYNGITIS |
4 |
0.0000 |
| 198 |
ARTHRALGIA |
9 |
0.0000 |
| 199 |
BACK PAIN |
5 |
0.0000 |
| 200 |
RENAL DISORDER |
1 |
0.0000 |
| 201 |
MIGRAINE |
2 |
0.0000 |
| 202 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 203 |
CELLULITIS |
1 |
0.0000 |
| 204 |
FLUID RETENTION |
1 |
0.0000 |
| 205 |
ERYTHEMA |
4 |
0.0000 |
| 206 |
INFLAMMATION |
1 |
0.0000 |
| 207 |
NERVOUSNESS |
1 |
0.0000 |
| 208 |
SPEECH DISORDER |
1 |
0.0000 |
| 209 |
DEPRESSED MOOD |
1 |
0.0000 |
| 210 |
DIARRHOEA |
12 |
0.0000 |
| 211 |
CONSTIPATION |
4 |
0.0000 |
| 212 |
NECK PAIN |
1 |
0.0000 |
| 213 |
COVID-19 |
3 |
0.0000 |
| 214 |
SURGERY |
1 |
0.0000 |
| 215 |
VOMITING |
8 |
0.0000 |
| 216 |
VERTIGO |
1 |
0.0000 |
| 217 |
PRURITUS |
6 |
0.0000 |
| 218 |
HYPERHIDROSIS |
2 |
0.0000 |
| 219 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 220 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 221 |
PYREXIA |
5 |
0.0000 |
| 222 |
WEIGHT DECREASED |
4 |
0.0000 |
| 223 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 224 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 225 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 226 |
MOBILITY DECREASED |
1 |
0.0000 |
| 227 |
WEIGHT INCREASED |
3 |
0.0000 |
| 228 |
ASTHENIA |
5 |
0.0000 |
| 229 |
HALLUCINATION |
1 |
0.0000 |
| 230 |
ACNE |
1 |
0.0000 |
| 231 |
DECREASED APPETITE |
3 |
0.0000 |
| 232 |
ARTHRITIS |
1 |
0.0000 |
| 233 |
PARAESTHESIA |
2 |
0.0000 |
| 234 |
THROMBOSIS |
1 |
0.0000 |
| 235 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 236 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 237 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 238 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 239 |
PAIN |
7 |
0.0000 |
| 240 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 241 |
MUSCLE SPASMS |
2 |
0.0000 |
| 242 |
CHEST PAIN |
2 |
0.0000 |
| 243 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 244 |
BREAST CANCER |
1 |
0.0000 |
| 245 |
DYSPNOEA |
6 |
0.0000 |
| 246 |
DYSPHAGIA |
1 |
0.0000 |
| 247 |
HEART RATE INCREASED |
1 |
0.0000 |
| 248 |
HYPOTENSION |
2 |
0.0000 |
| 249 |
HYPERTENSION |
2 |
0.0000 |
| 250 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 251 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 252 |
RASH |
4 |
0.0000 |
| 253 |
FALL |
3 |
0.0000 |
| 254 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 255 |
DEPRESSION |
2 |
0.0000 |
| 256 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 257 |
CHILLS |
1 |
0.0000 |
| 258 |
FEELING ABNORMAL |
2 |
0.0000 |
| 259 |
JOINT SWELLING |
1 |
0.0000 |
| 260 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 261 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 262 |
PSORIASIS |
1 |
0.0000 |
| 263 |
DRUG INEFFECTIVE |
10 |
0.0000 |
| 264 |
RENAL FAILURE |
1 |
0.0000 |
| 265 |
DEHYDRATION |
1 |
0.0000 |
| 266 |
DRY SKIN |
1 |
0.0000 |
| 267 |
VISION BLURRED |
1 |
0.0000 |
| 268 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 269 |
COUGH |
2 |
0.0000 |
| 270 |
ANXIETY |
2 |
0.0000 |
| 271 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 272 |
HYPOAESTHESIA |
1 |
0.0000 |
| 273 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 274 |
DRUG INTERACTION |
1 |
0.0000 |
| 275 |
PNEUMONIA |
2 |
0.0000 |
| 276 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 277 |
MYALGIA |
1 |
0.0000 |
| 278 |
OFF LABEL USE |
4 |
0.0000 |
| 279 |
DEATH |
1 |
0.0000 |